Peptide-based cancer therapy: opportunity and challenge.


Cancer is one of the leading causes of death worldwide. Conventional cancer therapies mainly focus on mass cell killing without high specificity and often cause severe side effects and toxicities. Peptides are a novel class of anticancer agents that could specifically target cancer cells with lower toxicity to normal tissues, which will offer new… (More)
DOI: 10.1016/j.canlet.2014.05.002